微信扫码

用户中心
意见反馈
  • 15216886416
   宇劲生物
登录 | 注册 设为首页 收藏本站 购物车
Cloud Zoom small image
品牌：Enzo（Alexis）   货号：ALX-420-025-M025

CAS号：170632-47-0

     独立于一氧化氮（NO）的可溶性鸟苷酸环化酶（SGC）的超氧化物敏感刺激物，EC50 = 18.6uM。在培养的细胞和兔主动脉环中诱导cGMP水平的浓度依赖性增加。抑制血小板与胶原蛋白的粘附。非特异性磷酸二酯酶抑制剂。 YC-1抑制肿瘤中的HIF-a活性，导致血管生成受阻并抑制肿瘤生长。抑制Na+通道。

名称：YC-1 鸟苷酸环化酶激活剂
更多推荐 > >
可在线通过咨询了解详情
 
通过以下按钮进入下一步
马上咨询
在线询价
  • 详情
  • 评价
品牌货号产品名称规格
EnzoALX-420-025-M025YC-125 mg


Nitric oxide (NO) independent, superoxide-sensitive stimulator of soluble guanylyl cyclase (sGC), EC50=18.6μM. Induces concentration-dependent increase in cGMP levels in cultured cells and in rabbit aortic rings. Inhibits platelet adhesion to collagen. Non-specific phosphodiesterase inhibitor. YC-1 inhibits HIF-α activity in tumors resulting in blocked angiogenesis and an inhibition of tumor growth. Inhibits Na+ channel.Binds to [3H]BW202W92.

Product Specification

Formula:C19H16N2O2
MW:304.4
CAS:170632-47-0
Purity:≥98% (HPLC)
Identity:Identity determined by 1H-NMR.
Appearance:White to pale yellow powder.
Solubility:Soluble in DMSO, methanol or dichloromethane.
Shipping:Ambient
Long Term Storage:+4°C
Handling:Protect from light.


Product Literature References

Expression of N-WASP is regulated by HiF1α through the hypoxia response element in the N-WASP promoter: A. Salvi & T. Thanabalu; Biochem. Biophys. Rep. 9, 13 (2016), Abstract; Full Text
Selection, Analysis and Improvement of Anti-Angiogenesis Compounds Identified by an Anti-HIF-1α Screening and Validation System: C. Madu, et al.; J. Cancer 7, 1926 (2016), Application(s): Screening for anti-HIF-1α compounds and chemical modification of the lead compound G3, Abstract; Full Text
A Novel Drug Binding Site on Voltage-Gated Sodium Channels in Rat Brain: D. R. Riddall, et al.; Mol. Pharmacol. 69, 278 (2006), Abstract;
Soluble guanylyl cyclase activator YC-1 protects white matter axons from nitric oxide toxicity and metabolic stress, probably through Na(+) channel inhibition: G. Garthwaite, et al.; Mol. Pharmacol. 61, 97 (2002), Abstract;
Generation and characterization of a stable soluble guanylate cyclase-overexpressing CHO cell line: E.M. Becker, et al.; Nitric Oxide 3, 55 (1999), Abstract;
Mechanism of YC-1-induced activation of soluble guanylyl cyclase: A. Friebe & D. Koesling; Mol. Pharmacol. 53, 123 (1998), Abstract; Full Text
Nitric oxide-sensitive guanylyl cyclase inhibits acetylcholine release and excitatory motor transmission in the guinea-pig ileum: K. Hebeiss & H. Kilbinger; Neuroscience 82, 623 (1998), Abstract;
Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide: J.R. Stone & M.A. Marletta; Chem. Biol. 5, 255 (1998), Abstract;
Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat: J.W. Wegener, et al.; Br. J. Pharmacol. 122, 1523 (1997), Abstract;
Differential effects of isoliquiritigenin and YC-1 in rat aortic smooth muscle: J.W. Wegener & H. Nawrath; Eur. J. Pharmacol. 323, 89 (1997), Abstract;
Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators: A. Mülsch, et al.; Br. J. Pharmacol. 120, 681 (1997), Abstract;
Inhibition of platelet adhesion to collagen by cGMP-elevating agents: C.C. Wu, et al.; BBRC 231, 412 (1997), Abstract;
YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase: C.C. Wu, et al.; Br. J. Pharmacol. 116, 1973 (1995), Abstract;
YC-1, a novel activator of platelet guanylate cyclase: F.N. Ko, et al.; Blood 84, 4226 (1994), Abstract;

General Literature References

YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1: E.J. Yeo, et al.; J. Natl. Cancer Inst. 95, 516 (2003), Abstract;
Inhibition of extracellular Ca(2+) entry by YC-1, an activator of soluble guanylyl cyclase, through a cyclic GMP-independent pathway in rat neutrophils: J.P. Wang, et al.; Biochem. Pharmacol. 62, 679 (2001), Abstract;
Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells: K. Schmidt, et al.; Mol. Pharmacol. 59, 220 (2001), Abstract;
Prolonged exposure to YC-1 induces apoptosis in adrenomedullary endothelial and chromaffin cells through a cGMP-independent mechanism: R. Ferrero & M. Torres; Neuropharmacology 41, 895 (2001), Abstract;
YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components: E. Martin, et al.; Proc. Natl. Acad. Sci. USA 98, 12938 (2001), Abstract;




特别推荐